• 대한기계학회논문집B
• /
• 제34권4호
• /
• pp.365-373
• /
• 2010

제트 혼합 반응기(JSR) 내의 NOx와 같은 배출물질을 예측하기 위해서 화학반응기 모델을 개발했다. 본 연구에서는 JSR에 대한 화학반응기 모델로서 two-PSR 모델이 채택되었다. CHEMKIN 코드와 4가지 NO 생성 메커니즘을 포함한 GRI 3.0 메탄-공기 연소 메커니즘을 이용해서 JSR내의 희박 예혼합 메탄-공기 연소의 NO 생성예측을 실시하였다. 모델의 검증을 위해서 계산된 결과를 Rutar의 실험 데이터와 비교하였다. NO 생성의 중요 파라미터와 4 가지 NO 경로의 기여도를 조사하였다. 화염 영역에서는 prompt 메커니즘이 주된 경로이고, 화염후영역에서는 Zeldovich 메커니즘이 주된 경로이다. 희박 예혼합 조건에서는 N2O 메카니즘이가 화염 및 화염후 영역 모두에서 중요한 경로이다.

• 한국자동차공학회논문집
• /
• 제17권5호
• /
• pp.46-52
• /
• 2009

In this study the predictions of NOx in methane-air lean premixed combustion in PSR were carried out with GRI 3.0 methane-air combustion mechanism and Zeldovich, nitrous oxide, prompt, and NNH NO formation mechanism by using CHEMKIN code. The results are compared to the JSR experimental data of Rutar for the validation of the model. This study concerns about the importance of the chemical pathways. The chemical pathway most likely to form the NO in methane-air lean-premixed combustion was investigated. The results obtained with the 4 different NO mechanisms for residence time(0.5-1.6ms) and pressure(3, 4.7, 6.5 atm) are compared and discussed.

• 한국수소및신에너지학회논문집
• /
• 제33권4호
• /
• pp.400-412
• /
• 2022

Hydrogen with high chemical reactivity and combustion efficiency, is expected to reduce greenhouse gas and CO emission. However, there is a problem of increase in NOx emission due to hydrogen combustion. MILD combustion technology has been proposed to resolve NOx emission. In this study, the characteristics of MILD combustion and NOx formation by flue gas recirculation (KV) in CH₄-H₂ mixture were analyzed and predicted using 0D premixed combustion model. The ignition delay time became shorter as the hydrogen co-firing rate increased, and longer as the recirculation rate increased. For NOx emission, EINO decreased as the KV increased, but EINO increased as the hydrogen co- firing rate increased. In particular, EINO was predicted to increase significiently above 80% hydrogen. Through the pathway analysis of NO formation, it was found that the influence of N₂O intermediate route and NNH route was enhanced for hydrogen co-firing.

• 한국수정란이식학회지
• /
• 제27권3호
• /
• pp.171-174
• /
• 2012

Various small molecules can be used to control major signaling pathways to enhance stemness and inhibit differentiation in murine embryonic stem cell (mESC) culture. Small molecules inhibiting the fibroblast growth factor (FGF)/ERK pathway can preserve pluripotent cells from stimulation of differentiation. In this study, we aimed to evaluate the effect of pluripotin (SC-1), an inhibitor of the FGF/ERK pathway, on the colony formation of outgrowing presumptive mESCs. After plating the zona pellucida-free blastocyst on the feeder layer, attached cell clumps was cultured with SC-1 until the endpoint of the experiment at passage 10. In this experiment, when the number of colonies was counted at passage 3, SC-1-treated group showed 3.4 fold more mESC colonies when compared with control group. However, after passage 4, there was no stimulating effect of SC-1 on the colony formation. In conclusion, SC-1 treatment can be used to promote mESC generation by increasing the number of early mESC colonies.

• Archives of Pharmacal Research
• /
• 제19권3호
• /
• pp.201-206
• /
• 1996

Nitric oxide (NO) is thought to be a second messenger involved in secretion. Upon stimulating pancreatic acinar cells with cholecystokinin-pancreozymin (CCK-PZ), NO formation has been shown to be associated with increased levels of cGMP (Seo et al., 1995). To elucidate the signaling pathway of VIP-induced enzyme secretion, we investigated the NO and cGMP synthesis steps as potential steps where two signal pathways triggered by CCK-PZ and VIP interact. The results obtained in this work provide evidence that increase in pancreatic enzyme secretion by treatment with VIP has no relationship with NOS activity and cGMP level. This conclusion was derived from the following findings that VIP treatment of rat pancreatic tissue increased amylase release as well as protein output in a dose- and time-dependent manner, whereas NOS activity and cGMP synthesis were not affected by VIP treatment as monitored by NOS activity assay and determining cGMP level, which was further confirmed by a NOS-inhibitor study. Consequently, CCK-PZ or VIP increases enzyme secretion in rat pancreatic tissue, but the two hormones are different in their mode of action. Together the results suggest that signaling pathway of VIP-induced enzyme secretion might either bypass the NO and cGMP synthesis steps or lie on a distinct pathway from CCK-PZ-induced pathway.

• 한국연소학회:학술대회논문집
• /
• 한국연소학회 2004년도 제29회 KOSCI SYMPOSIUM 논문집
• /
• pp.169-174
• /
• 2004

The NOx emission characteristics with oxygen enrichment in nonpremixed counterflow and coflow jet flame of $CH_4$ fuel have been investigated numerically. A small amount of nitrogen is included in oxygen-enriched combustion, in order to consider the inevitable $N_2$ contamination by air infiltration. The results show that the initial increase of NO with increasing oxygen enrichment is due to increasing temperature and residence time, while its subsequent decrease above 75% oxygen is due to decreasing the consumption rate of nitrogen. When oxygen addition exceeds 30%, Thermal NO gradually becomes the dominant production pathway and Prompt NO becomes negative pathway for net NO production rate. It is also seen that Thermal NO plays an important role in NO reduction when strain rate increase in oxygen-enriched combustion. Finally, the results of EINOx with oxygen enrichment in coflow jet flame show the similar profile with those of conterflow flame. It is confirmed that, with leakage of 1% nitrogen in the oxidizer stream, the corresponding EINOx is eight times of that emitted from regular $CH_4$/Air flame.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권16호
• /
• pp.7031-7038
• /
• 2015

Background: Arginine may play important roles in tumor progression by providing ornithine for polyamine biosynthesis, required for cell growth. The aim of this work was to determine the expression of arginine metabolic pathway enzymes in head and neck squamous cell carcinoma (HNSCC) in northeast India. Materials and Methods: The expressions of arginase isoforms (ARG1 and ARG2), ornithine aminotransferase (OAT) and ornithine decarboxylase (ODC) were examined in fifty paired HNSCC and adjacent non-tumor tissues by immunohistochemistry. Immunocytochemistry, semiquantitative reverse transcription sq-PCR and quantitative real-time qPCR were used to assess protein and mRNA expressions in peripheral blood of fifty HNSCC patients and hundred controls. Results: ARG1 and ODC protein and mRNA were strongly expressed in peripheral blood from HNSCC patients. No ARG2 expression was observed. In vivo, expression of ARG1, ARG2 and ODC was significantly higher in tumor than in non-tumor tissues. Most tumors expressed low levels of OAT, with no difference in tissues or blood, compared to controls. The absolute extent of maximal ARG1 upregulation with qPCR showed 6.23 fold increase in HNSCC. Conclusions: These findings strongly suggest that in HNSCCs, the ARG1 pathway is stimulated leading to the formation of polyamines as indicated by higher ODC expression, which promote tumor growth.

• Archives of Pharmacal Research
• /
• 제26권8호
• /
• pp.631-637
• /
• 2003

Chloroquine has been used for many decades in the prophylaxis and treatment of malaria. It is metabolized in humans through the N-dealkylation pathway, to desethylchloroquine (DCQ) and bisdesethylchloroquine (BDCQ), by cytochrome P450 (CYP). However, until recently, no data are available on the metabolic pathway of chloroquine. Therefore, the metabolic pathway of chloroquine was evaluated using human liver microsomes and cDNA-expressed CYPs. Chloroquine is mainly metabolized to DCQ, and its Eadie-Hofstee plots were biphasic, indicating the involvement of multiple enzymes, with apparent $K_m and V_{max}$ values of 0.21 mM and 1.02 nmol/min/mg protein 3.43 mM and 10.47 nmol/min/mg protein for high and low affinity components, respectively. Of the cDNA-expressing CYPs examined, CYP1A2, 2C8, 2C19, 2D6 and 3A4/5 exhibited significant DCQ formation. A study using chemical inhibitors showed only quercetin (a CYP2C8 inhibitor) and ketoconazole (a CYP3A4/5 inhibitor) inhibited the DCQ formation. In addition, the DCQ formation significantly correlated with the CYP3A4/5-catalyzed midazolam 1-hydroxylation (r=0.868) and CYP2C8-catalyzed paclitaxel 6$\alpha$-hydroxylation (r = 0.900). In conclusion, the results of the present study demonstrated that CYP2C8 and CYP3A4/5 are the major enzymes responsible for the chloroquine N-deethylation to DCQ in human liver microsomes.

• Molecules and Cells
• /
• 제42권8호
• /
• pp.604-616
• /
• 2019

Phosphoserine phosphatase (PSPH) is one of the key enzymes of the L-serine synthesis pathway. PSPH is reported to affect the progression and survival of several cancers in an L-serine synthesis-independent manner, but the mechanism remains elusive. We demonstrate that PSPH promotes lung cancer progression through a noncanonical L-serine-independent pathway. PSPH was significantly associated with the prognosis of lung cancer patients and regulated the invasion and colony formation of lung cancer cells. Interestingly, L-serine had no effect on the altered invasion and colony formation by PSPH. Upon measuring the phosphatase activity of PSPH on a serine-phosphorylated peptide, we found that PSPH dephosphorylated phospho-serine in peptide sequences. To identify the target proteins of PSPH, we analyzed the protein phosphorylation profile and the PSPH-interacting protein profile using proteomic analyses and found one putative target protein, IRS-1. Immunoprecipitation and immunoblot assays validated a specific interaction between PSPH and IRS-1 and the dephosphorylation of phospho-IRS-1 by PSPH in lung cancer cells. We suggest that the specific interaction and dephosphorylation activity of PSPH have novel therapeutic potential for lung cancer treatment, while the metabolic activity of PSPH, as a therapeutic target, is controversial.

• Preventive Nutrition and Food Science
• /
• 제20권4호
• /
• pp.221-229
• /
• 2015

Hesperidin has been shown to possess a potential inhibitory effect on vascular formation in endothelial cells. However, the fundamental mechanism for the anti-angiogenic activity of hesperidin is not fully understood. In the present study, we evaluated whether hesperidin has anti-angiogenic effects in mouse embryonic stem cell (mES)-derived endothelial-like cells, and human umbilical vascular endothelial cells (HUVECs), and evaluated their mechanism via the AKT/mammalian target of rapamycin (mTOR) signaling pathway. The endothelial cells were treated with several doses of hesperidin (12.5, 25, 50, and $100{\mu}M$) for 24 h. Cell viability and vascular formation were analyzed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and tube formation assay, respectively. Alteration of the AKT/mTOR signaling in vascular formation was analyzed by western blot. In addition, a mouse aortic ring assay was used to determine the effect of hesperidin on vascular formation. There were no differences between the viability of mES-derived endothelial-like cells and HUVECs after hesperidin treatment. However, hesperidin significantly inhibited cell migration and tube formation of HUVECs (P<0.05) and suppressed sprouting of microvessels in the mouse aortic ring assay. Moreover, hesperidin suppressed the expression of AKT and mTOR in HUVECs. Taken together, these findings suggest that hesperidin inhibits vascular formation by blocking the AKT/mTOR signaling pathways.